Jag Dosanjh

Allergan plc is a bold, global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device and surgical products for patients around the world. Allergan global revenues totaled $15.8B for 2018 of which the Eyecare portfolio accounted for $3.5B. As Sr. Vice President, Eye Care for Allergan, Jag is responsible for the commercialization of the entire Eye Care portfolio in the United States and co-chairs the Global R&D Governance Board for the development of the pipeline and in-licensing of technologies. Prior to this role, Jag has led the Retina, Dermatology, and SkinMedica business units, the Managed Markets and Government Affairs functions at Allergan. Jag has also led the Global Strategic Marketing function developing the strategy and delivery of the pipeline across the pharmaceutical, device and aesthetics portfolios. Prior to joining Allergan, Jag worked at GlaxoSmithKline for over 15 years in several executive roles in both Europe and the United States. Jag holds a BA (Hons) degree in Business Studies from Sheffield in the UK.